Coherus BioSciences’ $57.5 Million Follow-On Offering

Latham & Watkins advised Coherus BioSciences, and Davis Polk advised J.P. Morgan Securities LLC and Citigroup Global Markets Inc. on the offering.Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), a…

This content is for members only.
Login to Read More Join Now

PrintFriendly

Insight Partners’ Investment in Kabal

Lockheed Martin’s $2 Billion Senior Notes Offering

3M Company’s $4.25 Billion Revolving Credit Facility

Cepera’s R$55 Million Agribusiness Receivables Certificates Issuance

Eurofarma’s R$500 Millon Debentures Issuance

Promedon’s US$3,7 Million Notes Issuance

Sandberg Development AB’s Investment in Silanos S.r.l.

ProductLife Group’s Acquisition of Cilatus

Niterra’s Investment in Neoplas Med GmbH

Telecom Egypt SAE’s Sale of Shares on the Secondary Market at EGX

Scatec’s Joint Development Agreement with Alexandria National Refining and Petrochemicals Company

FMO and CAP’s Co-Investment in Merensky Timber

Volumez’s $20 Million Series A Financing

Helios’ Acquisition of Interest in Tlamim Project

Gav Yam’s Bonds Offering

OFX’s Acquisition of Paytron

Australian Silicon Valley’s Investment in Fetch Metals Limited

Papa John’s International’s Franchise Agreement with PJP Investments Group

Paul Hastings Adds Litigation Partner Susan Leader in Century City

Weil Adds Energy Partner Chris Bennett in Houston

Linklaters Continues U.S. Expansion with Arrival of Market-Leading Litigation Partner Robin Nunn

Presumption of “Tax Inversion”: The Italian Supreme Court Clarifues That “Mediated” Control Is Not Relevant

Italian DPA: Company Fined For Failure To Monitor Its Suppliers

The (Un)Happy Relationship Between SIAE And Meta in Italy

Paul Hastings Adds Litigation Partner Susan Leader in Century City

Weil Adds Energy Partner Chris Bennett in Houston

Linklaters Continues U.S. Expansion with Arrival of Market-Leading Litigation Partner Robin Nunn

Coherus BioSciences’ $57.5 Million Follow-On Offering

Author: Leila Ahmed